Cardiovascular Systems (NSDQ:CSII) priced a public offering of some 2 million shares of CSII stock at $17.60 apiece, saying it expects to net about $33 million from the deal.
Cardiovascular Systems prices $33M offering | Wall Street Beat
Kips Bay Medical Inc.
Holaira raises $10M for lung device | Wall Street Beat
Medical device company Holaira said it drummed up $10 million, changed its name and moved its headquarters.
Formerly known as Innovative Pulmonary Solutions, Holaira said it plans to use the Series C round to develop its minimally invasive devices to treat obstructive lung disease. All of Holaira’s existing backers participated, namely Advanced Technology Ventures, Morgenthaler Ventures, Split Rock Partners, and Versant Ventures.
Echo Therapeutics prices offering | Wall Street Beat
Echo Therapeutics (NSDQ:ECTE) priced its public stock offering at 75¢ per share, saying it expects to raise about $10 million in gross proceeds.
The 13.3 million-share offering includes a 45-day over-allotment option for bookrunner Aegis Capital for another 2 million shares.
Kips Bay closes $6.5M funding
Minneapolis-based device maker Kips Bay Medical (NSDQ:KIPS) closed its $6.5 million public offering of 10,000,000 shares of its common stock, hoping to use the funds to seek regulatory approval for its eSVS Mesh system worldwide.
Mako Surgical prices $40M offering | Wall Street Beat
Mako Surgical (NSDQ:MAKO) priced a stock offering of more than 3 million shares at $13.15 apiece, raising some $40 million in total.
Kips Bay lands FDA approval to begin eSVS mesh study
Kips Bay Medical (NSDQ:KIPS) won conditional FDA investigational device exemption approval for its eSVS mesh, allowing the company to begin a clinical study of the device in use during coronary artery bypass procedures.
Study: Kips Bay begins U.S. feasibility trial for vascular mesh
Kips Bay Medical (NSDQ:KIPS) launched the 1st feasibility trials aimed at gaining FDA investigational device clearance for its eSVS vascular mesh.
The eSVS is designed to help keep vein grafts open in patients undergoing coronary artery bypass surgery, according to the company’s brochure.
Electromed CEO Robert Hansen retires after 20 years at the helm | Personnel Moves
Electromed (NSDQ:ELMD) founder, chairman & CEO Robert Hansen relinquished control of the company after 20 years steering the ship.
Bovie swings to 2011 black | Earnings Roundup
Incoming BSX CEO Mahoney’s 2011 total tops $11.5M | Personnel Moves
Device tax spurs Hill-Rom to lay off 200 | Wall Street Beat
Hill-Rom Holdings (NYSE:HRC) said it will lay off about 3% of its workforce, or roughly 200 workers, as it maneuvers to confront the medical device tax set to go into effect next year.
